Which YC batch was Algen Biotechnologies in?

Algen Biotechnologies was in Y Combinator's Winter 2020 batch (W20).

Is Algen Biotechnologies still active?

Y Combinator lists Algen Biotechnologies as active.

Where is Algen Biotechnologies based?

Algen Biotechnologies lists San Francisco, CA, USA as its location on YC's directory.

Algen Biotechnologies: YC W20 company, active

Founders

Not read from YC yet; the weekly run fills these in.

Same space

Competitors

Closest in what they build, same category.

Arpeggio BioS19Arpeggio Bio develops drugs targeting transcription factors using AI…Shared: biotech, drug discoveryActive

Adjacent

Overlapping tags, a different niche.

AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, therapeutics, drug discoveryActive
Adventris PharmaceuticalsW23Adventris makes cancer vaccinesShared: biotech, therapeutics, drug discoveryActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeutics, drug discoveryActive
ParcelBioW24Elevated mRNA for transformative medicines.Shared: biotech, therapeutics, drug discoveryActive
Valink TherapeuticsW21Discovering bispecific antibody drug-conjugates (BsADC) against cancerShared: biotech, therapeutics, drug discoveryActive

Also from W20 in AI

Batchmates in Winter 2020.

About Algen Biotechnologies

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.

San Francisco, CA, USA